All In Biotech

Free tool

FAERS Monitor: Aldactone

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 012151 or its brand name (Aldactone, Spironolactone). Reports on generic versions are filed under their own applications.

Reports

142,744

Serious

111,491

78% of reports

Hospitalization

67,450

Death reported

18,312

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea11,078
  • fatigue8,762
  • nausea8,345
  • diarrhoea8,003
  • acute kidney injury7,153
  • dizziness6,673
  • headache6,414
  • hypotension6,175
  • off label use6,086
  • drug ineffective5,550
  • fall5,362
  • asthenia5,282
  • death5,212
  • vomiting5,144
  • hyperkalaemia5,096

Reports by year received

View as table
YearReports
20041,611
20051,925
20061,911
20071,861
20082,088
20092,528
20103,341
20113,581
20124,304
20133,937
20145,469
20157,144
20168,776
20178,042
20189,684
20199,988
20209,246
20218,774
20228,916
20239,822
202410,781
202510,709
20268,302

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,911,415 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hyperkalaemiaSignal5,09624.924.2100,002
acute kidney injurySignal7,1537.27.036,502
hypotensionSignal6,1754.64.517,298
dyspnoeaSignal11,0782.92.914,100
fallSignal5,3622.42.34,360
astheniaSignal5,2822.12.02,993
dizziness6,6732.01.93,293
diarrhoea8,0031.81.83,110
fatigue8,7621.71.62,393
vomiting5,1441.61.61,231
nausea8,3451.61.51,722
headache6,4141.51.51,136
off label use6,0861.01.04
death5,2120.90.972
drug ineffective5,5500.60.61,383

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.